Letter to the editor RE: Lake et al., 2022 comment on Fulford et al., 2021 'A point-of-care lateral flow assay for neutralizing antibodies against SARS-CoV-2'
EBioMedicine
.
2022 Mar:77:103899.
doi: 10.1016/j.ebiom.2022.103899.
Epub 2022 Mar 9.
Authors
David A Anderson
1
,
Dale I Godfrey
2
Affiliations
1
Burnet Institute, Melbourne, Australia.
2
Microbiology and Immunology, The University of Melbourne, Melbourne, Australia. Electronic address: godfrey@unimelb.edu.au.
PMID:
35278742
PMCID:
PMC8905072
DOI:
10.1016/j.ebiom.2022.103899
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Neutralizing* / immunology
Antibodies, Viral
COVID-19*
Humans
Point-of-Care Systems
SARS-CoV-2
Substances
Antibodies, Neutralizing
Antibodies, Viral